About Depuy Synthes
Depuy Synthes offers a portfolio of orthopedic and neuro products and services for joint reconstruction, trauma, spine, sports medicine, neuro, craniomaxillofacial, power tools and biomaterials. Acquired by Johnson & Johnson in 1998, its companies form part of the Johnson & Johnson Medical Devices group. DePuy develops and markets products under the Codman, DePuy Mitek, DePuy Orthopaedics and DePuy Spine brands.
Depuy Synthes Patents
Depuy Synthes has filed 3557 patents.
Bones of the vertebral column, Spinal nerves, Bones of the thorax, Skeletal system, Pelvis
Bones of the vertebral column, Spinal nerves, Bones of the thorax, Skeletal system, Pelvis
Latest Depuy Synthes News
Sep 21, 2023
| Industry Forecasts to 2030 Spinal Fusion Devices Market Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product Type (Thoracolumbar Devices, Cervical Fixation Devices, and Interbody Fusion Devices), Surgery Type (Open Spine Surgery and Minimally Invasive Spine Surgery), Disease Indications (Degenerative Disc, Trauma and Fractures, Complex Deformity, and Others), End User (Hospitals, Specialty Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America) Publication Month : Sep 2023 [Research Report] The spinal fusion devices market size is expected to grow from US$ 8,276.31 million in 2022 and to reach a value of US$ 12,902.46 million by 2030, it is anticipated to record a CAGR of 5.8% from 2022 to 2030. Market Insights and Analyst View: The spinal fusion devices market size is growing rapidly due to the increase in number of spinal fusion devices cases due to increase in cases of gallstones. Also, increase in cases of diabetes fuel the growth of the market. In addition, strategic initiatives by companies for the market development are fueling the growth of the market. In September 2022, GE Healthcare announced US FDA 510(k) clearance of its breakthrough AIR Recon DL for 3D and PROPELLER imaging sequences. The advantages of AIR Recon DL are extended by these new features to almost all Magnetic Resonance Imaging (MRI) clinical procedures, covering all anatomies and enabling better image quality, shorter scan times, and enhanced patient experience. Thus, a significant rise in revolutionary technologies to address customer needs is likely to bring new trends in the market during the forecast period. Opportunities and Challenges: Spinal fusion surgeries are much costlier; many patients slide back from the decision to undergo spinal surgeries. Also, in many cases, the cost of spinal implants is not covered under health insurance plans, limiting the number of surgeries. For instance, a country like the US is expensive; according to the Healthcare Bluebook data published in February 2022, the top 5 cities are listed with the cost of lumbar spinal fusion: Denver: US$ 86,182, San Jose, California: US$ 78,809 San Francisco: US$ 78,809, Indianapolis: US$ 77,269, and Seattle: US$ 74,499. At the same time, the least cost for lumbar spinal fusion is ~ US$ 48,000 in cities such as Memphis, Tenn, and San Antonio. On the other hand, medical tourism has enabled to offer spinal fusion surgeries at cheaper costs. Countries in developing regions have significantly developed medical tourism and have advanced technologies that provide world-class medical services at cheaper rates. Lyfboat Technologies Pvt. data published on July 2023 stated that countries such as India, Thailand, Turkey, the UAE, and Egypt are considered best for offering scoliosis surgery between US$ 8,000 and US$ 16,000. The data published by Lyfboat Technologies Pvt also reveals the cost of spinal fusion surgery in Egypt is US$ 10,897, and in the UAE, it is ~ US$ 8,200. Similarly, in Turkey, the cost of spinal fusion surgery is US$ 15,000 and in India is nearly between US$ 8000 and US$ 12,000. Also, the cost of thoracoplasty in India is between US$ 2,500 and US$ 4,000. Offering critical surgeries at cheaper costs increases patient flow to these countries for their medical treatments. Also, the availability of advanced medical techniques and increasing government funding to increase medical tourism are leading to the increasing demand for advanced surgical implants. Further, the advancing healthcare infrastructure in developing countries will likely continue the demand for advanced medical devices, enhancing growth opportunities for the spinal fusion devices market. Regulatory requirements for spinal fusion devices are different from the other implantable devices. The regulations for spinal fusion devices are regularly updated to maintain the quality of products to offer enhanced quality of life to patients. In March 2023, the Food and Drug Administration (FDA) updated medical devices, orthopedic devices, classification of spinal spheres for use in intervertebral fusion procedures (final rule) final regulatory impact analysis. According to the FDA’s analysis, spinal devices are classified as Class III. The devices will require separate filing for pre-market approval applications. Moreover, the FDA found that general and special controls are insufficient to assure the devices' effectiveness and safety. Therefore, it is expected that companies must provide complete product descriptions and analyses for product efficiency and safety to avoid confusion concerning the product’s material and specifications for sizes and intentions of clinical condition. Similarly, the regulations in developing countries are updating regulatory requirements for spinal fusion devices. In November 2021, the Australian government's Department of Health and Aged Care Therapeutic Goods Administration (TGA) revised the regulatory framework for spinal implantable medical devices. TGA aims to support sponsors and manufacturers with new regulatory requirements to understand and comply with the updated requirements. TGA has proposed four major requirements for the manufacturers, which include the need for specific information in the ARTG entry about Class IIb spinal fusion devices; TGA’s mandatory audit assessment for device inclusion applications, including assessment of clinical evidence; conformity assessment documents that demonstrate appropriate procedures for device classification, and manufacturer’s exhaustive assessment for the quality management systems and technical documentation related to each device. Thus, the strictness of the regulations for manufacturers will lead to more economic investments, and the risk of recalls may lead to losses. Therefore, the stringent regulations for spinal fusion devices are among the factors hindering the market growth. Customize Research To Suit Your Requirement We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making. Market Size Value by Growth rate Forecast Period Have a question? Akshay will walk you through a 15-minute call to present the report’s content and answer all queries if you have any. Report Segmentation and Scope: The spinal fusion devices market share is divided on the basis of product type, surgery type, disease indication, and end user. The spinal fusion devices market, by product type, is segmented into thoracolumbar devices, cervical fixation devices, and interbody fusion devices. The spinal fusion devices market, by surgery type, is bifurcated into open spine surgery and minimally invasive spine surgery. The spinal fusion devices market, by disease indications, is segmented into degenerative disc, trauma and fractures, complex deformity, and others. The spinal fusion devices market, by end user, is segment into hospitals, specialty clinics, others. Based on geography, the market is divided into North America (the US, Canada, and Mexico), Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe), Asia Pacific (China, Japan, India, South Korea, Australia, and the Rest of Asia Pacific), Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and the Rest of South & Central America). Download Free Sample Request discounts available for Start-Ups & Universities Segmental Analysis: Based on surgery type, the Spinal Fusion Devices Market is bifurcated into open spine surgery and minimally invasive spine surgery. In 2022, the open spine surgery segment held a larger share of the market by surgery. The minimally invasive spine surgery segment is estimated to grow at a higher CAGR during 2022–2030 due to increasing adoption of minimally invasive spine surgery approach. Open surgeries are considered standard surgeries as they offer complete exposure to the anatomy. Open spine surgery is recommended to treat conditions such as scoliosis, severe degeneration of the discs, spine instability, or a combination of these problems. Open surgery is widely preferred if the condition is severe and complex; it provides a larger exposure to anatomy, offering ease for the procedure and greater visibility of surrounding structures. However, there are several risks associated with open spine surgery type. The risk includes excessive blood loss and longer recovery time. In many cases, open spine surgery type may reverse the symptoms of spinal disorders. Complications may also lead to infection, poor wound healing, blood clots, and damage to surrounding veins or nerves. Minimally invasive spine surgery type (MISS) has gained notable attention over traditional open spine surgery type. MISS requires smaller incisions; therefore, convincing patients to undergo MISS is easier. Other advantages such as avoiding damage to the surrounding muscles, less bleeding, less pain, faster recovery, and shorter hospital stays have increased the adoption of MISS. At present, MISS is considered a common procedure for spinal fusion. The higher adoption of MISS includes treating spinal problems in older and critically sick people by limiting the risks and changing reimbursement patterns and patient preferences. In addition, transformations in MISS have introduced new intraoperative imaging techniques by combining powerful software. The combination of imaging techniques and software allows real-time navigation for surgeons to supplement their understanding of the spine's 3-dimensional (3D) anatomy. Thus, the transformation in MISS is leading to the segment's fastest growth, eventually driving market growth. According to an article titled “Minimally Invasive Spine Surgery Type: An Overview,” published in July 2022, ~75% of 1.2 million spine procedures in the US are performed annually by MISS techniques. Similarly, an article, “Spinal Endoscopy: Evidence, Techniques, Global Trends, and Future Projections,” published in January 2022, stated that 96.7% of Asian surgeons perform MISS. Thus, considering the increasing number of MISS procedures, the market is anticipated to grow notably in the coming years. Spinal Fusion Devices Market, by Surgery Type – 2022 and 2030 Request discounts available for Start-Ups & Universities The spinal fusion devices market, by product type, is segmented into thoracolumbar devices, cervical fixation devices , and interbody fusion devices. In 2022, the thoracolumbar devices segment held the largest share of the market by product type. The interbody fusion devices segment is estimated to grow at a significant CAGR during 2022–2030 due to growing developments for the interbody fusion devices. The spinal fusion devices market, by disease indication, is categorized into degenerative disc, trauma and fractures, complex deformity, and others. In 2022, the degenerative disc segment held the largest share of the market by disease indications and is estimated to grow at a significant CAGR during 2022–2030 due to growing geriatric population that are more prone to degenerative diseases. The spinal fusion devices market, by end user, is segment into hospitals, specialty clinics, others. In 2022, the hospitals segment held the largest share of the market and is expected to grow at the fastest rate during the coming years. Regional Analysis: Based on geography, the spinal fusion devices market is divided into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. North America is the largest contributor to the growth of the market, and Asia Pacific is the fastest-growing region. The spinal fusion devices market in North America is segmented into the US, Canada, and Mexico. In 2022, the US held the largest market share in this region and is expected to continue its dominance during the forecast period. DePuy Synthes, Stryker, Aurora Spine, and Alevio Spine are among the major players operating in the spinal fusion devices market in the US. Product developments and launches driven by these players favor the market growth. Technologically advanced spinal fusion devices approved by the Food and Drug Administration (FDA) are widely adopted in the US. Following is the list of spinal fusion devices recently approved by the FDA: In May 2023, CTL Amedica received FDA 510(k) clearance for the commercialization of the NITRO Interbody Fusion Cage System, which is exclusively made by the fusion of biomaterial silicon nitride. Silicon nitride material is compatible with all imaging modalities; it exhibits unique bacteriostatic properties and provides artifact-free imaging. In January 2023, Alevio Spine received 510 (K) clearance of additional indications for the SI-Cure SI Joint Fusion System. The expanded indication includes sacroiliac fusion for skeletally mature patients undergoing sacropelvic fixation as part of a lumbar or thoracolumbar fusion. In June 2022, the US FDA granted 510K clearance for Aurora Spine’s DEXA SOLO-L anterior lumbar interbody fusion device (ALIF). Based on DEXA Technology Platform, a 3D printed standalone device was designed for anterior and lateral lumbar interbody fusion (ALIF & LLIF) procedures. Age-related wear-and-tear triggers the prevalence of lower back pain (LBP) among the geriatric population in the US, in turn, fuels the demand for spinal fusion devices. According to National Health Services in 2022, lifetime incidence of LBP in the US is reported to be 60–90%, with annual incidence of 5%. The source also states that 14.3% of new patients visit physicians each year because of LBP, and ~13 million people visit physician due to chronic LBP. Industry Developments and Future Opportunities: Various initiatives by key players operating in the Spinal Fusion Devices Market are listed below: In February 2023, Globus Medical Inc, a prominent musculoskeletal solutions provider, and NUVASIVE, a pioneer in spine technology innovation, agreed to merge in an all-stock transaction. The transaction brings together two well-known musculoskeletal technology companies with a common vision of innovation in the relentless pursuit of unmet clinical requirements to improve patient care. In November 2022, Centinel Spine LLC announced the first implantation of its prodisc C SK Cervical Total Disc Replacement (TDR) product. The prodisc C SK system is the second of the three new products to be released. In March 2022, DePuy Synthes Inc acquired CUPTIMIZE Hip-Spine Analysis, providing surgeons with an easy-to-use tool for better understanding and addressing the impact of aberrant mobility between the spine and pelvis in some patients requiring total hip arthroplasty (THA). CUPTIMIZE Hip-Spine Analysis improves the surgical planning capabilities of VELYS Hip Navigation, one of DePuy Synthes' VELYS Digital Surgery platforms of connected technologies. Competitive Landscape and Key Companies: A few prominent players operating in the spinal fusion devices market are Medtronic PLC, Johnson & Johnson Services Inc, B.Braun SE, Stryker Corp, ATEC Spine Inc, Globus Medical Inc, NuVasive Inc, ZimVie Inc, Centinel Spine LLC, and Orthofix Medical Inc. These companies focus on new product launches and geographic expansions to meet the growing consumer demand worldwide and increase their product range in specialty portfolios. Their global presence allows them to serve a large set of customers, subsequently allowing them to expand their market share. Report Coverage Orthofix Medical Inc. The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review. Data Collection and Secondary Research: As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain. Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends. Primary Research: The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team. For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise. A typical research interview fulfils the following functions: Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook Validates and strengthens in-house secondary research findings Develops the analysis team’s expertise and market understanding Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to: Industry participants: VPs, business development managers, market intelligence managers and national sales managers Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry. Below is the breakup of our primary respondents by company, designation, and region: Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection. Data Analysis: Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level. 3.1 Macro-Economic Factor Analysis: We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities. 3.2 Country Level Data: Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential. 3.3 Company Profile: The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size. 3.4 Developing Base Number: Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis. Data Triangulation and Final Review: The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization. We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports. We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time. Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out. Submit
Depuy Synthes Frequently Asked Questions (FAQ)
When was Depuy Synthes founded?
Depuy Synthes was founded in 1895.
Where is Depuy Synthes's headquarters?
Depuy Synthes's headquarters is located at 700 Orthopaedic Drive, Warsaw.
What is Depuy Synthes's latest funding round?
Depuy Synthes's latest funding round is Acquired.
Who are the investors of Depuy Synthes?
Investors of Depuy Synthes include Johnson & Johnson.
Who are Depuy Synthes's competitors?
Competitors of Depuy Synthes include Arthrex and 7 more.
Compare Depuy Synthes to Competitors
Inovedis develops surgical devices. It offers a surgical technique for rotator cuff ruptures. It develops SINEFIX, a surgical technique and implant system for shoulder injuries that allows refixation of the tendon with a simplified surgical technique and is optimized for minimally invasive surgery. It was founded in 2019 and is based in Albstadt, Germany.
Nela Biodynamics offers a novel modular system for intramedullary implants with a wide range of applications.
SUTUREGARD operates as a medical device company. It manufactures and commercializes surgical products that simplify wound closure. It was formerly known as Autumn Sunshine. It was founded in 2015 and is based in Corvallis, Oregon.
flowbone develops injectable nano biomaterials technology. It involves the development and promotion of a biomaterial for the minimal-invasive augmentation of fragile bones at high risk of fracture. It follows a treatment approach allowing a fragilized bone to strengthen itself without impeding bone mechanics or blood flow within the bone. The company was founded in 2020 and is based in Vaud, Switzerland.
Zeta Surgical operates as a digital surgery company. The company's navigation and robotics platform Zeta leverages computer vision and artificial intelligence technology to unlock the use of image guidance directly at the point of care, enabling new possibilities in fields such as emergency care and interventional medicine. The company was formerly known as Z Imaging. It was founded in 2018 and is based in Boston, Massachusetts.
Precise Light Surgical is a medical device company focused on endoscopic surgery. The company's Flash Vaporization technology provides precision and control for the removal of delicate tissues to improve patient outcomes and reduce surgical risk and downtime while lowering treatment costs.